Phase II trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical and vaginal cancer. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback